Sleeping Bruxism Treatment Market Trends

  • Report ID: 6939
  • Published Date: Aug 13, 2025
  • Report Format: PDF, PPT

Sleeping Bruxism Treatment Market Growth Drivers and Challenges:

Growth Drivers  

  • Increasing adoption of botulinum toxin therapy: The application of botulinum toxin (Botox) has emerged as a highly effective solution for managing severe cases of bruxism, gaining widespread popularity. By targeting and reducing excessive jaw muscle activity, Botox helps alleviate pain, prevent dental damage, and improve overall quality of life. As published in the National Library of Medicine in January 2024, the social domain improved significantly from 65.3 to 73.4 over 12 months with botulinum toxin therapy. Its minimally invasive nature, quick administration, and long-lasting effects make it for an appealing choice for patients seeking effective treatment, driving increased adoption among healthcare providers and patients alike. Thus, propelling the sleeping bruxism treatment market.
  • Growing demand for non-invasive treatments: Patients are increasingly opting for non-invasive or minimally invasive treatments to manage bruxism, prioritizing options that offer effective results without the risks associated with surgery. Therapies such as behavioral interventions, relaxation techniques, and medications are gaining traction due to their convenience, safety, and focus on addressing underlying causes. This shift in preference has significantly boosted the demand for these solutions, as they cater to the growing need for personalized and less intrusive treatment approaches, in turn, propagating the sleeping bruxism treatment market.

Challenge

  • High cost of advanced treatment: Advanced solutions for bruxism treatment, such as custom-made dental appliances and botulinum toxin therapy, can be prohibitively expensive, making them less accessible for patients with lower disposable incomes. The high cost of these treatments often acts as a barrier, causing patients to delay or forgo seeking professional care. As a result, the adoption rate in the sleeping bruxism treatment market is impacted, and many individuals continue to suffer from untreated bruxism-related symptoms.
  • Dependance on behavioral compliance: Non-invasive treatments for bruxism, such as stress management and behavioral therapy, rely heavily on consistent patient effort and compliance to the effective. Patients must actively engage in techniques like relaxation exercises and cognitive behavioral therapy to achieve meaningful results. However, lack of adherence to these interventions due to factors like time constraints, lifestyle challenges, or lack of motivation can significantly reduce the success rates of treatments and, in turn, limit overall sleeping bruxism treatment market growth.

Base Year

2025

Forecast Period

2026-2035

CAGR

4.6%

Base Year Market Size (2025)

USD 559.87 million

Forecast Year Market Size (2035)

USD 877.82 million

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of sleeping bruxism treatment is estimated at USD 583.05 million.

Sleeping Bruxism Treatment Market size was over USD 559.87 million in 2025 and is poised to exceed USD 877.82 million by 2035, growing at over 4.6% CAGR during the forecast period i.e., between 2026-2035.

North America dominates the Sleeping Bruxism Treatment Market with a 39.5% share, driven by rising bruxism cases, stress awareness, and innovations in diagnostic and non-invasive treatment options, ensuring leadership through 2026–2035.

Key players in the market include Carestream Dental, Akervall Technologies Inc., Planmeca Oy.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos